mackinnon
Avalanche forward Nathan MacKinnon scores a pair then drops gloves, might be the best player in the world
NFL sideline reporter Melanie Collins does it again, Sydney Sweeney to the moon & Tomlin's Minecraft reveal MLB fans explode as fishy images of Sonny Gray's neck raise eyebrows after Red Sox get trounced Jerry Jones goes all in as Cowboys trade for Steelers' Joey Porter Jr in hopes of Super Bowl push Players and media hate Fever fans for one simple reason: They think they're conservative Patrick McEnroe on U.S. Open weed smell, trans athletes, foreign recruits reshaping college tennis AEW airs gripping Jon Moxley promo to start Pac tribute show after wrestler's death The Rock shares heartfelt words on Pac following AEW star's shocking death at 40 Anticipation builds as MIke Tomlin prepares to unveil his Minecraft city that's 12 years in the making Dr. Siegel explains why inmate's execution may have failed Kat Timpf details breast cancer journey, unveils new podcast'The Girls' Mother seeks synthetic kratom ban after son's death NHL players and Olympic gold medalists Brady and Matthew Tkachuk discuss the pride of representing the USA in sports. They reflect on their Olympic hockey wins and offer advice to the current US soccer team in the World Cup. Wednesday night was the start of several NHL teams' seasons, and one team that started things with crazy high expectations is the Colorado Avalanche . The 2022 Stanley Cup winners have championship aspirations pretty much every season, and a big reason for that is because they have a guy on their team by the name of Nathan MacKinnon. This page may contain affiliate links to legal sports betting partners.
Improved Inference for CSDID Using the Cluster Jackknife
Karim, Sunny R., Nielsen, Morten Ørregaard, MacKinnon, James G., Webb, Matthew D.
Obtaining reliable inferences with traditional difference-in-differences (DiD) methods can be difficult. Problems can arise when both outcomes and errors are serially correlated, when there are few clusters or few treated clusters, when cluster sizes vary greatly, and in various other cases. In recent years, recognition of the ``staggered adoption'' problem has shifted the focus away from inference towards consistent estimation of treatment effects. One of the most popular new estimators is the CSDID procedure of Callaway and Sant'Anna (2021). We find that the issues of over-rejection with few clusters and/or few treated clusters are at least as severe for CSDID as for traditional DiD methods. We also propose using a cluster jackknife for inference with CSDID, which simulations suggest greatly improves inference. We provide software packages in Stata csdidjack and R didjack to calculate cluster-jackknife standard errors easily.
Are dating apps fuelling addiction? Lawsuit against Tinder, Hinge and Match claims so
Many of us have had bad experiences of being swiped left, ghosted, breadcrumbed and benched on internet dating apps – though few people have ever thought to take their heartbreak to court. On Valentine's Day, six dating app users filed a proposed class-action lawsuit accusing Tinder, Hinge and other Match dating apps of using addictive, game-like features to encourage compulsive use. Match's apps, according to the lawsuit filed in federal court in the Northern District of California, "employ recognised dopamine-manipulating product features" to turn users into "gamblers locked in a search for psychological rewards", generating "market success by fomenting dating app addiction that drives expensive subscriptions and perpetual use". Match said the lawsuit was "ridiculous", but online dating experts said it reflected a broader backlash to the way apps were gamifying human experience for profit and leaving people feeling manipulated. "I'm not at all surprised that this has come to litigation. I think big tech is the new big tobacco, as smartphones are just as addictive as cigarettes," said Mia Levitin, author of The Future of Seduction.
Medopad gets $28M to connect patients and providers with mobile, AI tools
Artificial intelligence healthcare technology company Medopad has just landed $28 million in a Series A funding round with lead investments from China's NWS Holdings. But the company announced that its goal is to raise $120 million in the next few months. This funding comes after Medopad struck a series of 15 trade deals with Chinese firms, collectively worth more than $140 million (100 million pounds). Medopad was a member of the trade delegation that the UK recently sent to Beijing and Shanghai. "We now have several amazing strategic investors in the business, which is a great achievement for us as we gear for significant growth and scale our business," Dan Vahdat, CEO of Medopad, said in a statement.